Sofinnova: At the Intersection of Life Science, Finance & Innovation
Since its genesis in 1974, Sofinnova has been funding futures. We are a clinical-stage biopharmaceutical investment firm with approximately $1.8B in assets under management and committed capital.* We invest in both private and public equity of therapeutics-focused companies
Our Mission: to improve the lives of patients through science. We strive to provide outstanding results for those we serve: patients, entrepreneurs, and the investors that entrust us with their capital.